These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
174 related articles for article (PubMed ID: 11828504)
1. The activation of fibroblast growth factors by heparin: synthesis, structure, and biological activity of heparin-like oligosaccharides. de Paz JL; Angulo J; Lassaletta JM; Nieto PM; Redondo-Horcajo M; Lozano RM; Giménez-Gallego G; Martín-Lomas M Chembiochem; 2001 Sep; 2(9):673-85. PubMed ID: 11828504 [TBL] [Abstract][Full Text] [Related]
2. The activation of fibroblast growth factors (FGFs) by glycosaminoglycans: influence of the sulfation pattern on the biological activity of FGF-1. Angulo J; Ojeda R; de Paz JL; Lucas R; Nieto PM; Lozano RM; Redondo-Horcajo M; Giménez-Gallego G; Martín-Lomas M Chembiochem; 2004 Jan; 5(1):55-61. PubMed ID: 14695513 [TBL] [Abstract][Full Text] [Related]
3. Solution NMR structure of a human FGF-1 monomer, activated by a hexasaccharide heparin-analogue. Canales A; Lozano R; López-Méndez B; Angulo J; Ojeda R; Nieto PM; Martín-Lomas M; Giménez-Gallego G; Jiménez-Barbero J FEBS J; 2006 Oct; 273(20):4716-27. PubMed ID: 16995857 [TBL] [Abstract][Full Text] [Related]
4. Biochemical and pharmacologic rationale for the development of a synthetic heparin pentasaccharide. Walenga JM; Jeske WP; Bara L; Samama MM; Fareed J Thromb Res; 1997 Apr; 86(1):1-36. PubMed ID: 9172284 [No Abstract] [Full Text] [Related]
5. Effect of new synthetic heparin mimetics on whole blood thrombin generation in vivo and in vitro in rats. Hérault JP; Bernat A; Gaich C; Herbert M Thromb Haemost; 2002 Feb; 87(2):238-44. PubMed ID: 11858483 [TBL] [Abstract][Full Text] [Related]
6. Structural requirements in heparin for binding and activation of FGF-1 and FGF-4 are different from that for FGF-2. Ishihara M Glycobiology; 1994 Dec; 4(6):817-24. PubMed ID: 7537556 [TBL] [Abstract][Full Text] [Related]
7. Degeneracy of the Antithrombin Binding Sequence in Heparin: 2-O-Sulfated Iduronic Acid Can Replace the Critical Glucuronic Acid. Elli S; Stancanelli E; Wang Z; Petitou M; Liu J; Guerrini M Chemistry; 2020 Sep; 26(51):11814-11818. PubMed ID: 32515841 [TBL] [Abstract][Full Text] [Related]
8. Synthesis and structural study of two new heparin-like hexasaccharides. Lucas R; Angulo J; Nieto PM; Martín-Lomas M Org Biomol Chem; 2003 Jul; 1(13):2253-66. PubMed ID: 12945695 [TBL] [Abstract][Full Text] [Related]
9. Interaction of heparins with fibroblast growth factors: conformational aspects. Guerrini M; Hricovíni M; Torri G Curr Pharm Des; 2007; 13(20):2045-56. PubMed ID: 17627538 [TBL] [Abstract][Full Text] [Related]
10. Structural studies of octasaccharides derived from the low-sulfated repeating disaccharide region and octasaccharide serines derived from the protein linkage region of porcine intestinal heparin. Yamada S; Sakamoto K; Tsuda H; Yoshida K; Sugiura M; Sugahara K Biochemistry; 1999 Jan; 38(2):838-47. PubMed ID: 9888825 [TBL] [Abstract][Full Text] [Related]
11. Preparation and structural characterization of large heparin-derived oligosaccharides. Pervin A; Gallo C; Jandik KA; Han XJ; Linhardt RJ Glycobiology; 1995 Feb; 5(1):83-95. PubMed ID: 7772871 [TBL] [Abstract][Full Text] [Related]
12. Dynamic properties of biologically active synthetic heparin-like hexasaccharides. Angulo J; Hricovíni M; Gairi M; Guerrini M; de Paz JL; Ojeda R; Martín-Lomas M; Nieto PM Glycobiology; 2005 Oct; 15(10):1008-15. PubMed ID: 15958415 [TBL] [Abstract][Full Text] [Related]
13. Heparin-dependent fibroblast growth factor activities: effects of defined heparin oligosaccharides. Zhou FY; Kan M; Owens RT; McKeehan WL; Thompson JA; Linhardt RJ; Höök M Eur J Cell Biol; 1997 May; 73(1):71-80. PubMed ID: 9174673 [TBL] [Abstract][Full Text] [Related]
14. Oligosaccharides corresponding to the regular sequence of heparin: chemical synthesis and interaction with FGF-2. Tabeur C; Mallet JM; Bono F; Herbert JM; Petitou M; Sinaÿ P Bioorg Med Chem; 1999 Sep; 7(9):2003-12. PubMed ID: 10530949 [TBL] [Abstract][Full Text] [Related]